1. Home
  2. FBIOP vs SBSI Comparison

FBIOP vs SBSI Comparison

Compare FBIOP & SBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIOP
  • SBSI
  • Stock Information
  • Founded
  • FBIOP N/A
  • SBSI 1960
  • Country
  • FBIOP United States
  • SBSI United States
  • Employees
  • FBIOP 186
  • SBSI N/A
  • Industry
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • SBSI Major Banks
  • Sector
  • FBIOP Health Care
  • SBSI Finance
  • Exchange
  • FBIOP Nasdaq
  • SBSI Nasdaq
  • Market Cap
  • FBIOP N/A
  • SBSI N/A
  • IPO Year
  • FBIOP N/A
  • SBSI N/A
  • Fundamental
  • Price
  • FBIOP $6.04
  • SBSI $30.34
  • Analyst Decision
  • FBIOP
  • SBSI Hold
  • Analyst Count
  • FBIOP 0
  • SBSI 2
  • Target Price
  • FBIOP N/A
  • SBSI $37.00
  • AVG Volume (30 Days)
  • FBIOP N/A
  • SBSI 99.4K
  • Earning Date
  • FBIOP N/A
  • SBSI 01-29-2025
  • Dividend Yield
  • FBIOP N/A
  • SBSI 4.75%
  • EPS Growth
  • FBIOP N/A
  • SBSI N/A
  • EPS
  • FBIOP N/A
  • SBSI 2.91
  • Revenue
  • FBIOP N/A
  • SBSI $254,514,000.00
  • Revenue This Year
  • FBIOP N/A
  • SBSI N/A
  • Revenue Next Year
  • FBIOP N/A
  • SBSI $5.41
  • P/E Ratio
  • FBIOP N/A
  • SBSI $10.43
  • Revenue Growth
  • FBIOP N/A
  • SBSI 5.30
  • 52 Week Low
  • FBIOP N/A
  • SBSI $25.30
  • 52 Week High
  • FBIOP N/A
  • SBSI $38.00
  • Technical
  • Relative Strength Index (RSI)
  • FBIOP 35.35
  • SBSI 39.12
  • Support Level
  • FBIOP $6.22
  • SBSI $31.12
  • Resistance Level
  • FBIOP $6.53
  • SBSI $32.32
  • Average True Range (ATR)
  • FBIOP 0.29
  • SBSI 0.74
  • MACD
  • FBIOP -0.06
  • SBSI -0.09
  • Stochastic Oscillator
  • FBIOP 14.00
  • SBSI 7.63

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Share on Social Networks: